Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 87

Similar articles for PubMed (Select 23745710)

1.

High age predicts low referral of hyperthyroid patients to specialized hospital departments: evidence for referral bias.

Carlé A, Pedersen IB, Perrild H, Ovesen L, Jørgensen T, Laurberg P.

Thyroid. 2013 Dec;23(12):1518-24. doi: 10.1089/thy.2013.0074. Epub 2013 Sep 3.

PMID:
23745710
2.

Mainly the younger hypothyroid patients are referred to hospital--evidence for referral bias.

Carlé A, Laurberg P, Pedersen IB, Knudsen N, Perrild H, Ovesen L, Rasmussen LB, Jørgensen T.

J Clin Epidemiol. 2009 Apr;62(4):446-51. doi: 10.1016/j.jclinepi.2008.06.016. Epub 2008 Oct 21. Review.

PMID:
18945587
3.

High serum osteoprotegerin levels in patients with hyperthyroidism: effect of medical treatment.

Amato G, Mazziotti G, Sorvillo F, Piscopo M, Lalli E, Biondi B, Iorio S, Molinari A, Giustina A, Carella C.

Bone. 2004 Sep;35(3):785-91.

PMID:
15336617
4.

Age and stress as determinants of the severity of hyperthyroidism caused by Graves' disease in newly diagnosed patients.

Vos XG, Smit N, Endert E, Brosschot JF, Tijssen JG, Wiersinga WM.

Eur J Endocrinol. 2009 Feb;160(2):193-9. doi: 10.1530/EJE-08-0573. Epub 2008 Oct 30.

5.
6.

[Clinical aspects of hyperthyroidism in areas of different supplies of iodine. Results of a European prospective study].

Reinwein D, Benker G, König MP, Pinchera A, Schatz H, Schleusener H.

Schweiz Med Wochenschr. 1987 Aug 22;117(34):1245-55. German.

PMID:
3672070
7.

Haemodynamic changes following treatment of subclinical and overt hyperthyroidism.

Faber J, Wiinberg N, Schifter S, Mehlsen J.

Eur J Endocrinol. 2001 Oct;145(4):391-6.

8.

Graves' hyperthyroidism and moderate alcohol consumption: evidence for disease prevention.

Carlé A, Bülow Pedersen I, Knudsen N, Perrild H, Ovesen L, Rasmussen LB, Jørgensen T, Laurberg P.

Clin Endocrinol (Oxf). 2013 Jul;79(1):111-9. doi: 10.1111/cen.12106. Epub 2013 Apr 19.

PMID:
23170908
9.

[The clinical and laboratory findings in Graves' multinodular type disease].

Grammaticos P, Vasiliou O, Papanastasiou E, Gerasimou G, Balaris V, Alexandris R, Liaros G, Dedousi E.

Hell J Nucl Med. 2006 Jan-Apr;9(1):53-9. Greek, Modern.

PMID:
16617399
10.

Severe hyperthyroidism: aetiology, clinical features and treatment outcome.

Iglesias P, Dévora O, García J, Tajada P, García-Arévalo C, Díez JJ.

Clin Endocrinol (Oxf). 2010 Apr;72(4):551-7. doi: 10.1111/j.1365-2265.2009.03682.x. Epub 2009 Aug 4.

PMID:
19681915
11.

Bone loss in hyperthyroid patients and in former hyperthyroid patients controlled on medical therapy: influence of aetiology and menopause.

Jódar E, Muñoz-Torres M, Escobar-Jiménez F, Quesada-Charneco M, Lund del Castillo JD.

Clin Endocrinol (Oxf). 1997 Sep;47(3):279-85.

PMID:
9373448
12.

Incidence rate and clinical features of hyperthyroidism in a long-term iodine sufficient area of Sweden (Gothenburg) 2003-2005.

Nyström HF, Jansson S, Berg G.

Clin Endocrinol (Oxf). 2013 May;78(5):768-76. doi: 10.1111/cen.12060.

PMID:
23421407
13.

Sustained control of Graves' hyperthyroidism during long-term low-dose antithyroid drug therapy of patients with severe Graves' orbitopathy.

Laurberg P, Berman DC, Andersen S, Bülow Pedersen I.

Thyroid. 2011 Sep;21(9):951-6. doi: 10.1089/thy.2011.0039. Epub 2011 Aug 11.

PMID:
21834677
14.

Serum cytokine levels in autoimmune and non-autoimmune hyperthyroid states.

Ward LS, Fernandes GA.

Braz J Med Biol Res. 2000 Jan;33(1):65-9.

16.

Clinical outcome of radioiodine treatment of hyperthyroidism: a follow-up study.

Berg G, Michanek A, Holmberg E, Nyström E.

J Intern Med. 1996 Feb;239(2):165-71.

PMID:
8568485
17.

Graves' disease and toxic nodular goiter are both associated with increased mortality but differ with respect to the cause of death: a Danish population-based register study.

Brandt F, Thvilum M, Almind D, Christensen K, Green A, Hegedüs L, Brix TH.

Thyroid. 2013 Apr;23(4):408-13. doi: 10.1089/thy.2012.0500. Epub 2013 Mar 18.

PMID:
23253072
18.

Increase of interferon-γ inducible CXCL9 and CXCL11 serum levels in patients with active Graves' disease and modulation by methimazole therapy.

Antonelli A, Ferrari SM, Corrado A, Ferrannini E, Fallahi P.

Thyroid. 2013 Nov;23(11):1461-9. doi: 10.1089/thy.2012.0485. Epub 2013 Sep 25.

PMID:
23721189
19.

[Radioiodine treatment of hyperthyroidism using a simplified dosimetric approach. Clinical results].

Giovanella L, De Palma D, Ceriani L, Vanoli P, Garancini S, Tordiglione M, Tarolo GL.

Radiol Med. 2000 Dec;100(6):480-3. Italian.

PMID:
11307510
20.

Incidence of hyperthyroidism in Sweden.

Abraham-Nordling M, Byström K, Törring O, Lantz M, Berg G, Calissendorff J, Nyström HF, Jansson S, Jörneskog G, Karlsson FA, Nyström E, Ohrling H, Orn T, Hallengren B, Wallin G.

Eur J Endocrinol. 2011 Dec;165(6):899-905. doi: 10.1530/EJE-11-0548. Epub 2011 Sep 9.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk